August 19"' 2025
The General Manager
Pa1‹istan Stocl‹ Exchange Liliiited Stock Exchange Building
Stoclt Excli‹inge Road, Karachi 74000
GlaxoSmithKline
Pakistan Limited35-Dockyard Road, West Wharf, Karachi - 74000, Pakistan
T +92 21 111 475 725
Dear Sir,
Subject: Boar if of Director s Meeting
Please be infoi ined that a meeting of the Board of Directors of CllaxoSinitliKline Pakistan Limited, for the considei'ation of the Financial Results of the Corrlpany for the half year ended June 30, 2025, will be held at GSI( Pakistan Limited Head Office at 35 Docl‹yard Road, West Wharf, lCaraclii on August 26, 2025 (Tuesday) at 12.30 pin.
The Corrlpany has declared a close period from August 20"', 2025, to August 26"', 2025 (both days inclusive) as requii'ed under clause 5.6.4 of the Rule Bool‹ of Pakistan Stock Exchange.
Accordingly, no Director, Chief Executive Officer, Chief Financial Officer, Corrlpany Secretary, Substantial Shareholder and any other Executives of the Company or their spouses shall directly/indirectly deal in the shares of the Company in any rnarlner during the closed per rod. The employees of GSIC Pakistan Limited have been conBnunicated the closed period, as required.
You may please inform the TRE Certificate Holders of the Exchange accordingly. Thanking you,
For GlaxoSlTlitliKliile Pakistan Limited,
Hina Mir Company Secretary
CC: Central Depository Corrlpany of Pakistan Limited CDC House, 99-B, B1ocl‹ B
S.M.C.H.S, Slia1ii'a-e-Faisal, I£araclii, 74000